Giorgia Giordano

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes.

The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes.

Journal: Cancer immunology, immunotherapy : CII

Published: April 16, 2025

Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells.

Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 11, 2024

Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach.

Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach.

Journal: International journal of molecular sciences

Published: June 01, 2024

Targeting the EphA2 pathway: could it be the way for bone sarcomas?

Targeting the EphA2 pathway: could it be the way for bone sarcomas?

Journal: Cell communication and signaling : CCS

Published: April 09, 2024

AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications.

AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications.

Journal: ACS medicinal chemistry letters

Published: March 31, 2024

Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach.

Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach.

Journal: International journal of molecular sciences

Published: February 22, 2024

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells.

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells.

Journal: Cancer gene therapy

Published: February 27, 2023

DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.

DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.

Journal: Frontiers in oncology

Published: December 27, 2021

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study.

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study.

Journal: Cancers

Published: November 22, 2021

EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.

EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.

Journal: Cells

Published: September 03, 2021

Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo.

Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo.

Journal: Molecular cancer therapeutics

Published: June 22, 2020

Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.

Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights.

Journal: Cancers

Published: May 19, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026